The overall objective of this proposal is to determine the role of cytokines in acute and chronic colitis, specifically whether a particular pattern, sequence or quantity of cytokines, produced mainly by CD4+ T cells, is responsible for the development of chronic colitis. Colonic inflammation will be induced in inbred mice by direct instillation into the distal colon of the contact sensitizing agent trinitrobenzene sulfuric acid (TNBS) dissolved in 50% ethanol. This allows the establishment of an immune reaction to hapten modified self antigens. The resulting colitis has acute and chronic phases and disease """"""""flares"""""""" can be induced by repeat enemas. Moreover, there appears from initial studies, to be a genetic susceptibility among inbred strains of mice. A second model of colitis, with a different mechanism of induction, will also be employed. In this model, lethally irradiated mice are reconstituted with T cell depleted, syngeneic bone marrow followed by treatment with Cyclosporine A (CsA) for 6 weeks. Upon cessation of CsA treatment, multiple inflammatory lesions develop with particularly severe colon involvement. In the TNBS model the production of multiple cytokines, including Interleukins 1-7, neutrophil- activating factor (IL-8), interferon-gamma (IFNgamma), tumor necrosis factor (TNFalpha/TNFbeta) and transforming growth factor beta(TGFbeta) will be measured during acute and chronic colitis and compared to the same cytokines produced during an acute self-limited colitis induced by acetic acid enema. In the CsA/BMT-induced colitis, production of the same cytokines will be measured at weekly intervals following cessation of CsA treatment. Cytokine production will be quantitated by bioassay of supernatants of short-term organ culture of full thickness colon biopsies and of draining lymph node mononuclear cells; and by Northern blot analysis of RNA extracted from inflamed colon tissue and draining lymph nodes. We will also use PCR amplification to identify cytokine mRNA in mononuclear cells isolated from inflamed colon. Because CD4+ T cells are main producers of, and regulators of cytokine secretion, the effect of in vivo manipulation of T cell subsets on the induction and chronicity of colitis will also be investigated. This will be achieved by depletion of T cell subsets by in vivo administration of monoclonal antibodies to CD4 or CD8 T cells. In addition, mice will be tolerized by oral feeding of TNBS in oil prior to the induction of colitis. Using these models, we will test the hypothesis changes in the cytokine sequence, pattern or quantity regulate the severity and chronicity of murine colitis and that this alteration may be due to the preferential activation of a certain subset of CD4+ T cells.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Jurisic, Giorgia; Sundberg, John P; Detmar, Michael (2013) Blockade of VEGF receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement. Inflamm Bowel Dis 19:1983-9
Luckey, C John; Weaver, Casey T (2012) Stem-cell-like qualities of immune memory; CD4+ T cells join the party. Cell Stem Cell 10:107-8
Jurisic, G; Sundberg, J P; Bleich, A et al. (2010) Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Genes Immun 11:219-31
Bleich, Andre; Büchler, Gwen; Beckwith, Jason et al. (2010) Cdcs1 a major colitis susceptibility locus in mice; subcongenic analysis reveals genetic complexity. Inflamm Bowel Dis 16:765-75
Maynard, Craig L; Weaver, Casey T (2008) Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol Rev 226:219-33
Elson, Charles O; Cong, Yingzi; Weaver, Casey T et al. (2007) Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359-70
Duverger, Alexandra; Jackson, Raymond J; van Ginkel, Frederick W et al. (2006) Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176:1776-83
Elson, Charles O; Cong, Yingzi; Qi, Fengxia et al. (2006) Molecular approaches to the role of the microbiota in inflammatory bowel disease. Ann N Y Acad Sci 1072:39-51
Konrad, Astrid; Cong, Yingzi; Duck, Wayne et al. (2006) Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 130:2050-9
van Ginkel, Frederik W; Jackson, Raymond J; Yoshino, Naoto et al. (2005) Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract. Infect Immun 73:6892-902

Showing the most recent 10 out of 101 publications